[{"address1": "500 West 5th Street", "address2": "Suite 1200", "city": "Austin", "state": "TX", "zip": "78701", "country": "United States", "phone": "512 900 4690", "website": "https://www.shattucklabs.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.", "fullTimeEmployees": 75, "companyOfficers": [{"maxAge": 1, "name": "Dr. Taylor H. Schreiber M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 792885, "exercisedValue": 0, "unexercisedValue": 357187}, {"maxAge": 1, "name": "Mr. Andrew R. Neill M.B.A.", "age": 37, "title": "Chief Financial Officer", "yearBorn": 1986, "fiscalYear": 2023, "totalPay": 603956, "exercisedValue": 0, "unexercisedValue": 496087}, {"maxAge": 1, "name": "Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.", "age": 64, "title": "Chief Medical Officer", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695243, "exercisedValue": 0, "unexercisedValue": 434807}, {"maxAge": 1, "name": "Dr. Abhinav A. Shukla Ph.D.", "age": 50, "title": "Chief Technical Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 567398, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Conor  Richardson CPA", "title": "Vice President of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Stout J.D., Ph.D.", "age": 48, "title": "General Counsel, Corporate Secretary and Chief Ethics & Compliance Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Casi  DeYoung", "age": 52, "title": "Chief Business Officer", "yearBorn": 1971, "fiscalYear": 2023, "totalPay": 523482, "exercisedValue": 0, "unexercisedValue": 493071}, {"maxAge": 1, "name": "Dr. Thomas  Lampkin Pharm.D.", "title": "Senior Vice President of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. George  Fromm Ph.D.", "title": "Chief Scientific Officer of ARC Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Suresh de Silva Ph.D.", "title": "Chief Scientific Officer of GADLEN Platform", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 4, "boardRisk": 6, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1727481600, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 3.72, "open": 3.77, "dayLow": 3.77, "dayHigh": 3.93, "regularMarketPreviousClose": 3.72, "regularMarketOpen": 3.77, "regularMarketDayLow": 3.77, "regularMarketDayHigh": 3.93, "beta": 1.736, "forwardPE": -2.3313253, "volume": 170077, "regularMarketVolume": 170077, "averageVolume": 234926, "averageVolume10days": 166370, "averageDailyVolume10Day": 166370, "bid": 3.83, "ask": 3.89, "bidSize": 400, "askSize": 400, "marketCap": 184704640, "fiftyTwoWeekLow": 1.33, "fiftyTwoWeekHigh": 11.76, "priceToSalesTrailing12Months": 44.78774, "fiftyDayAverage": 3.6412, "twoHundredDayAverage": 6.928, "currency": "USD", "enterpriseValue": 83179528, "floatShares": 27667498, "sharesOutstanding": 47727300, "sharesShort": 5486108, "sharesShortPriorMonth": 5313921, "sharesShortPreviousMonthDate": 1723680000, "dateShortInterest": 1726185600, "sharesPercentSharesOut": 0.1149, "heldPercentInsiders": 0.13337, "heldPercentInstitutions": 0.73379, "shortRatio": 36.16, "shortPercentOfFloat": 0.1727, "bookValue": 2.318, "priceToBook": 1.6695426, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -85284000, "trailingEps": -1.85, "forwardEps": -1.66, "enterpriseToRevenue": 20.17, "enterpriseToEbitda": -0.964, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "STTK", "underlyingSymbol": "STTK", "shortName": "Shattuck Labs, Inc.", "longName": "Shattuck Labs, Inc.", "firstTradeDateEpochUtc": 1602250200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "64a83d67-d0cd-3885-8206-d0f94edae33a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 3.87, "targetHighPrice": 16.0, "targetLowPrice": 8.0, "targetMeanPrice": 10.67, "targetMedianPrice": 8.0, "recommendationMean": 1.8, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 105344000, "totalCashPerShare": 2.207, "ebitda": -86318000, "totalDebt": 3819000, "quickRatio": 7.011, "currentRatio": 7.615, "totalRevenue": 4124000, "debtToEquity": 3.452, "revenuePerShare": 0.088, "returnOnAssets": -0.39741, "returnOnEquity": -0.68481004, "freeCashflow": -31852376, "operatingCashflow": -63230000, "revenueGrowth": 7.045, "operatingMargins": -14.27098, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-09-30"}]